Is Catalyst Pharmaceuticals, Inc. technically bullish or bearish?

As of 3 October 2025, the technical trend for Catalyst Pharmaceuticals, Inc. has changed from bearish to mildly bearish. The weekly MACD is bearish, while the monthly MACD is mildly bearish. The daily moving averages also indicate a mildly bearish stance. Bollinger Bands show a mixed signal with a mildly bearish weekly outlook and a bullish monthly perspective. The KST is bearish on a weekly basis and mildly bearish monthly, while the Dow Theory presents a mildly bullish weekly view but a mildly bearish monthly stance.
In terms of performance, Catalyst Pharmaceuticals has outperformed the S&P 500 over the past week and month, returning 6.76% and 5.31% respectively, while the S&P 500 returned 1.09% and 4.15%. However, year-to-date and one-year returns are negative compared to the S&P 500, with Catalyst at -0.14% and 4.83% versus the S&P's 14.18% and 17.82%. Over the longer term, Catalyst has significantly outperformed the S&P 500 over the past 5 and 10 years, with returns of 583.28% compared to 100.56% and 244.16%. Overall, the current technical stance is mildly bearish with mixed signals across various indicators.